Effect of DPP-IV Inhibitors on Occurence of Cancers and the Mechanism Using AGE and RAGE in Patients With Type 2 Diabetes
N/A
20 Years
95 Years
20 Years
95 Years
Not Enrolling
Both
Type 2 Diabetes Mellitus
Both
Type 2 Diabetes Mellitus
Trial Information
Effect of DPP-IV Inhibitors on Occurence of Cancers and the Mechanism Using AGE and RAGE in Patients With Type 2 Diabetes
The AGE and RAGE are measured using ELISA method in the laboratory of Department of
Pathophysiology and Therapeutics of Diabetes Vascular Complications, Kurume University,
School of Medicine, Japan before and for 5 years after administration of DPP-IV inhibitors.
Inclusion Criteria:
- Type 2 diabetes mellitus patients with or without cancer
- Patients who have no treatment with DPP-IV inhibitors.
- Outpatients regularly visiting hospital
- Patients 20 years old (gender is disregarded)
Exclusion Criteria:
- Patients with a serious complication in the heart, liver or kidney
- Pregnant or possibly pregnant patients, or lactating patients
- Patients participating in other clinical study.
- Other than the above, patients judged inappropriate as the subjects of this
study by the investigator
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Frequency of cancers
Outcome Time Frame:
Each one year within 5 years
Safety Issue:
Yes
Principal Investigator
Kyuzi Kamoi, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Nagaoka Red Cross Hospital
Authority:
Japan: Ministry of Health, Labor and Welfare
Study ID:
7-Kamoi
NCT ID:
NCT01588587
Start Date:
October 2012
Completion Date:
December 2017
Related Keywords:
- Type 2 Diabetes Mellitus
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
Name | Location |
|---|
